Catherine Wendling

Catherine Wendling is a seasoned professional in the pharmaceutical industry with extensive experience in regulatory affairs and project management, particularly in oncology and cardiovascular sectors. Since joining Servier in July 2012, Catherine has held key positions such as Global Asset Leader for Gastro-Intestinal tumors and Senior Global Regulatory Lead for Hematological malignancies and Solid Tumors. Previous roles include Department Manager for Regulatory Affairs in Europe and Regulatory Affairs Project Manager for Oncology/Lymphoma. Catherine's earlier career includes positions at Cegedim Strategic Data, GlaxoSmithKline, Quintiles, and Servier Labs Ltd, where skills in clinical study management and research were honed. Catherine holds a PharmD degree from the University of Rennes II, earned between 1994 and 2000.